2Yoko Yokoyama,Ken Fukunaga,Hiroki Ikeuchi,Koji Kamikozuru,Nobuyuki Hida,Yoshio Ohda,Masaki Iimuro,Koji Yoshida,Risa Kikuyama,Kyouichi Kato,Kazuko Nagase,Shirou Nakamura,Hiroto Miwa,Takayuki Matsumoto.??The CD4 + CD28 null and the regulatory CD4 + CD25 High T-cell phenotypes in patients with ulcerative colitis during active and quiescent disease, and following colectomy(J)Cytokine . 2011 (2)
3Murat Kekilli,Bilge Tunc,Yavuz Beyazit,Mevlut Kurt,Ibrahim Koral Onal,Aysel Ulker,Ibrahim Celalettin Haznedaroglu.??Circulating CD4+CD25+ Regulatory T Cells in the Pathobiology of Ulcerative Colitis and Concurrent Primary Sclerosing Cholangitis(J)Digestive Diseases and Sciences . 2013 (5)
4R. Dahlén,H. Strid,A. Lundgren,S. Isaksson,S. Raghavan,M. K. Magnusson,M. Simrén,H. Sj?vall,L. ?hman.??Infliximab Inhibits Activation and Effector Functions of Peripheral Blood T Cells in vitro from Patients with Clinically Active Ulcerative Colitis(J)Scand J Immunol . 2013 (3)
5<ce:link locator='fx1'/> A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis(J)Gastroenterology . 2007 (2)
